Hepatocellular Carcinoma (HCC) is the most prevalent primary malignancy of the liver, frequently arising in individuals with underlying Hepatitis B, Hepatitis C, or fatty liver cirrhosis.

Early Detection & Diagnostic Surveillance

Patients with chronic liver disease should undergo bi-annual screening comprising abdominal ultrasound and Serum Alpha-Fetoprotein (AFP) blood measurement. Triphasic CT or MRI liver protocol provides definitive tumor mapping.

Curative Treatment Options

  • Surgical Resection (Hepatectomy): Complete surgical removal of the tumor with clear margin in non-cirrhotic or well-compensated cirrhotic patients.
  • Radiofrequency Ablation (RFA): Thermal destruction for small localized lesions.
  • Evaluation for Liver Transplantation: Offering a total cure by replacing the diseased liver and tumor within Milan criteria.